New Post: The Mount Sinai Resilience Project and the Ion Proton | Behind the Bench http://t.co/BHIWMQIAYM
4:06pm September 23rd 2014 via Hootsuite
Predicting and Preventing the Spread of Infectious Disease with Google Earth | Singularity Hub http://t.co/Punr0HTluM
1:02pm September 23rd 2014 via Hootsuite
Learning about mouse learning using optogenetic techniques at the NIH #ResearchFest - fascinating amount of control by locale & behavior
10:43am September 23rd 2014 via Hootsuite
RT @gatesfoundation: Why cheap text-based phones are the phones that will really change the world: http://t.co/L5cbfKVQoE
9:01am September 23rd 2014 via Hootsuite
RT @Forbes: Uber is squeezing every last drop out of its drivers' pay, & it's starting with its newest recruits: http://t.co/6uHdAR0Wt4
8:05am September 23rd 2014 via Hootsuite
3 Days with the iPhone 6+ on Vimeo http://t.co/xAIY7AiBbg
7:01am September 23rd 2014 via Hootsuite
RT @kirkenglehardt: Are we truly suppressing the creative side of science? http://t.co/iO0OG9wIdZ via @exmamaku #scicomm
6:05am September 23rd 2014 via Hootsuite
RT @gizmag: NASA'S MAVEN spacecrft succesfully arrives at Mars - http://t.co/E7GunJ0COQ
5:05am September 23rd 2014 via Hootsuite
Ariosa study finds arrays deliver 'more accurate' NIPT results than NGS in shorter time | BioArray News http://t.co/RqMKSSW7ZW
4:00am September 23rd 2014 via Hootsuite
The 4 reasons I switched from Google to Bing | PCWorld http://t.co/tRY4b65yV5
10:00pm September 22nd 2014 via Hootsuite
» Can your spouse’s personality get you a raise? http://t.co/E916LyKF9z http://t.co/ncM2y7XmAv
9:00pm September 22nd 2014 via Hootsuite
Brains grow and shrink like 'rainbows' as we age - Futurity http://t.co/SvcvM6dBdv
8:01pm September 22nd 2014 via Hootsuite
RT @dgmacarthur: The pervasive myth of the 10:1 ratio of microbial to human cells in our bodies: http://t.co/eh7WXAOjN3 via @markgenome
7:01pm September 22nd 2014 via Hootsuite
Did you get the full story about artificial sweeteners and diabetes? - Quartz http://t.co/4tk3o7SKyC
6:00pm September 22nd 2014 via Hootsuite
Apple iPhone 6 Plus (hands on): Already replaced my Android phone | ZDNet http://t.co/eS354WGWmO
5:01pm September 22nd 2014 via Hootsuite
SK: 'Broad skill sets desired esp. in a start-up environment'; technical and communication; dev time often >10y #ResearchFest
3:51pm September 22nd 2014 via Hootsuite
SK: 'Few great research discoveries result in approved products' 1/7 to 1/10 Ph I candidates make it through #ResearchFest
3:50pm September 22nd 2014 via Hootsuite
SK:Recommendations: understand motivations, competency, LT goals. Understand difference bet. personal & corporate goals #ResearchFest
3:49pm September 22nd 2014 via Hootsuite
SK: Work w/ TIGR, discovery work, applied work; biz dev and IP work expanded horizons and skill-sets #ResearchFest
3:48pm September 22nd 2014 via Hootsuite
SK: People felt he was 'crazy' to leave NIH in 1990 to join MedImmune. Rose to head of research there; HPV work lic. to GSK #ResearchFest
3:46pm September 22nd 2014 via Hootsuite
SK: History: 6y intramural in HIV; 11y at MedImmune HIV, RSV, HPV, CMV, bizdev, IP; 14y at MacroGenics #ResearchFest
3:41pm September 22nd 2014 via Hootsuite
SK: Showed pipeline, furthest along is margetuximab (HER2) in Phase III. 3 for automimmune disease incl. T1D #ResearchFest
3:38pm September 22nd 2014 via Hootsuite
SK: 3 Techs: Multi-specific Ab technology; Fc optimization; cancer stem-like cells for novel target ID, drug screening #ResearchFest
3:29pm September 22nd 2014 via Hootsuite
SK: Founded to meet unmet needs in cancer, autoimmune disease. 4 oncology products in clinical dev. NASDAQ:MGNX 197 empl. #ResearchFest
3:27pm September 22nd 2014 via Hootsuite
Scott Koenig NIAID now MacroGenics "Skills and knowledge acquired at NIH which helped start my commercial sector career" #ResearchFest
3:24pm September 22nd 2014 via Hootsuite
VH:Advice: don't pigeonhole yourself; get around (via a network) filling out all the boxes. #ResearchFest
3:22pm September 22nd 2014 via Hootsuite
VH: She writes grants from various sources; $400M to-date. DoD's concerns differ from HHS. #ResearchFest
3:14pm September 22nd 2014 via Hootsuite
VH: Took technical writing courses; organized retreats at the NCI; built needed connections (a great opp'y here at NIH) #ResearchFest
3:09pm September 22nd 2014 via Hootsuite
VH:Was a post-doc in Wiltrout's NCI lab; 'communication is one of the biggest skills in business for scientists' #ResearchFest
3:07pm September 22nd 2014 via Hootsuite
Veronica Hall NCI now Emergent Biosolutions "Using tools from the NIH to move to a career in industry" #ResearchFest
3:05pm September 22nd 2014 via Hootsuite
JM:Q:Advice? A:Add value. How biotech works - very long time-frames, >10y. Acquire IP #ResearchFest
3:04pm September 22nd 2014 via Hootsuite
JM: 2013 'Reflections' on the discover of Ca19 http://t.co/qAzezDZNfV #ResearchFest
3:02pm September 22nd 2014 via Hootsuite
JM: GMI-1271 now launched clinical trial; Glycomimetics (NASDAQ:GLYC) first to go public in 2014; 34 employees #ResearchFest
3:00pm September 22nd 2014 via Hootsuite
JM: GMI-1271: targeting bone marrow microenv. for AML. E-selectin stimulates exp of genes for survival in AML blasts #ResearchFest
2:58pm September 22nd 2014 via Hootsuite
JM:Opioid analgesic reduced by 83%; very little self-administered by patients #ResearchFest
2:53pm September 22nd 2014 via Hootsuite
JM: GMI-1070 called Rivipansel P2 trial: median time to discharge reduced by 84h (expectation 24h reduction) #ResearchFest
2:52pm September 22nd 2014 via Hootsuite
JM: In '11 Pfizer invested $340M license. Looked at cell adhesion markers, activation markers inhibition, coag cascade in PI #ResearchFest
2:51pm September 22nd 2014 via Hootsuite
JM: VOC among sickle-cell sufferers, >78K hospitalizations/year, ave 6.1d visit, no treatment #ResearchFest
2:49pm September 22nd 2014 via Hootsuite
JM: Now moving to vaso-occlusion process as it involves GMI-1070; application to sickle-cell (affects >100K in US) #ResearchFest
2:48pm September 22nd 2014 via Hootsuite
JM: Carbohydrate groups although labile, can be used to help rational drug design. Replace residues, maintain interactions #ResearchFest
2:42pm September 22nd 2014 via Hootsuite
JM: Sialyl Le^a a functional tumor marker for Gastric cancer, also binding ligand for E-selectin #ResearchFest
2:40pm September 22nd 2014 via Hootsuite
JM: In 1980's, TLC plates staining with mAb's showed discovery of Siayl Le^a: CA-19-9 antigen, a Pancreatic Ca antigen #ResearchFest
2:38pm September 22nd 2014 via Hootsuite
JM: Highlights work of Victor Ginsburg, a glycobiology pioneer. 1964 PNAS: http://t.co/xNDmHSY8rJ #ResearchFest
2:36pm September 22nd 2014 via Hootsuite
John Magnani, NIDDK now GlycoMimetics. "A new source of therapeutic oppy's for treating sickle cell, cancer, & other diseases" #Research
2:31pm September 22nd 2014 via Hootsuite
BW:A:Stay optimistic and passionate. #ResearchFest
2:30pm September 22nd 2014 via Hootsuite
BW:Q:Advice? A:Be risk averse. Don't disclose anything, line up everything, file the IP, grill everyone carefully. #ResearchFest
2:29pm September 22nd 2014 via Hootsuite
BW: Keynes: "The market can stay irrational longer than you can stay solvent." Makes case for the need for continued SBIR's #ResearchFest
2:27pm September 22nd 2014 via Hootsuite
BW: His wife: "I thought it would be a Wed nite steak at the clinic. Never in my life did I think it would be farm animals" #ResearchFest
2:26pm September 22nd 2014 via Hootsuite
BW: TrophoGen's SBIR grants: $9.8M cumulative, non-diluting investment. Pages of IP and new glycosylation. #ResearchFest
2:25pm September 22nd 2014 via Hootsuite
BW: Bovine superovulation, bovine/porcine maturation. On verge of large Animal Health opportunity - stay tuned. #ResearchFest
2:22pm September 22nd 2014 via Hootsuite
